Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 63Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 44Glioblastoma 42Stomach Neoplasms 37Esophageal Neoplasms 33Brain Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Colorectal Neoplasms 29Pancreatic Neoplasms 26Lung Neoplasms 24Neoplasms 23Glioma 23Astrocytoma 22Neoplasm Metastasis 21Head and Neck Neoplasms 19Sarcoma 17Gliosarcoma 15Esophageal Squamous Cell Carcinoma 15Central Nervous System Neoplasms 15Ovarian Neoplasms 14Oligodendroglioma 13Melanoma 13Colonic Neoplasms 12Adenocarcinoma Of Esophagus 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Carcinoma, Hepatocellular 11Oropharyngeal Neoplasms 9Carcinoma, Ovarian Epithelial 9

Interventions

pyrotinib 2Surgical Procedures, Operative 2pertuzumab 1Trastuzumab 1Mastectomy 1Leuprolide 1Goserelin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Invasive × Surgical Procedures, Operative × Clear all
NCT06716073 2024-12-04

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
1,380 enrolled
Breast

Breast Cancer Invasive

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Shanghai Jiao Tong University School of Medicine

Phase 2 Active not recruiting
216 enrolled
Breast

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡